196 related articles for article (PubMed ID: 12007688)
1. Atrial natriuretic peptide level after cardioversion of chronic atrial fibrillation.
Wozakowska-Kaplon B; Opolski G
Int J Cardiol; 2002 May; 83(2):159-65. PubMed ID: 12007688
[TBL] [Abstract][Full Text] [Related]
2. Effects of sinus rhythm restoration in patients with persistent atrial fibrillation: a clinical, echocardiographic and hormonal study.
Wozakowska-Kapłon B; Opolski G
Int J Cardiol; 2004 Aug; 96(2):171-6. PubMed ID: 15262030
[TBL] [Abstract][Full Text] [Related]
3. Atrial natriuretic peptide before and after cardioversion of persistent atrial fibrillation.
Wozakowska-Kapłon B; Opolski G; Janion M
Kardiol Pol; 2003 Apr; 58(4):255-63. PubMed ID: 14517556
[TBL] [Abstract][Full Text] [Related]
4. The effects of left ventricular diastolic function on natriuretic peptide levels after cardioversion of atrial fibrillation.
Bakowski D; Wozakowska-Kapłon B; Opolski G
Kardiol Pol; 2009 Apr; 67(4):361-7. PubMed ID: 19492248
[TBL] [Abstract][Full Text] [Related]
5. An increase in plasma atrial natriuretic peptide concentration during exercise predicts a successful cardioversion and maintenance of sinus rhythm in patients with chronic atrial fibrillation.
Wozakowska-Kaplon B; Opolski G; Kosior D; Janion M
Pacing Clin Electrophysiol; 2000 Nov; 23(11 Pt 2):1876-9. PubMed ID: 11139947
[TBL] [Abstract][Full Text] [Related]
6. The dubious value of echocardiographic and plasma ANP measurements in predicting outcome of cardioversion in patients with persistent atrial fibrillation.
Wozakowska-Kapłon B; Opolski G
Int J Cardiol; 2005 Sep; 103(3):280-5. PubMed ID: 16098390
[TBL] [Abstract][Full Text] [Related]
7. Concomitant recovery of atrial mechanical and endocrine function after cardioversion in patients with persistent atrial fibrillation.
Wozakowska-Kapłon B; Opolski G
J Am Coll Cardiol; 2003 May; 41(10):1716-20. PubMed ID: 12767653
[TBL] [Abstract][Full Text] [Related]
8. Plasma NT-proANP in patients with persistent atrial fibrillation who underwent successful cardioversion.
Bartkowiak R; Wozakowska-Kapłon B; Janiszewska G
Kardiol Pol; 2010 Jan; 68(1):48-54. PubMed ID: 20131188
[TBL] [Abstract][Full Text] [Related]
9. The predictive value of plasma brain natriuretic peptide for the recurrence of atrial fibrillation six months after external cardioversion.
Ari H; Binici S; Ari S; Akkaya M; Koca V; Bozat T; Gürdoğan M
Turk Kardiyol Dern Ars; 2008 Oct; 36(7):456-60. PubMed ID: 19155659
[TBL] [Abstract][Full Text] [Related]
10. B-type natriuretic peptide level after sinus rhythm restoration in patients with persistent atrial fibrillation - clinical significance.
Wozakowska-Kapłon B; Bartkowiak R; Grabowska U; Janiszewska G
Kardiol Pol; 2010 Jul; 68(7):781-6. PubMed ID: 20648436
[TBL] [Abstract][Full Text] [Related]
11. Alternations in atrial natriuretic peptide release after DC cardioversion of non-valvular chronic atrial fibrillation.
Arakawa M; Miwa H; Noda T; Ito Y; Kambara K; Kagawa K; Nishigaki K; Kano A; Hirakawa S
Eur Heart J; 1995 Jul; 16(7):977-85. PubMed ID: 7498215
[TBL] [Abstract][Full Text] [Related]
12. Decreased plasma brain natriuretic peptide levels after a successful maze procedure.
Watanabe M; Murakami M; Furukawa H; Nakahara H; Tanaka H; Sunamori M
J Heart Valve Dis; 2003 May; 12(3):287-91. PubMed ID: 12803326
[TBL] [Abstract][Full Text] [Related]
13. Plasma biomarkers as predictors of recurrence of atrial fibrillation.
Lewicka E; Dudzińska-Gehrmann J; Dąbrowska-Kugacka A; Zagożdżon P; Stepnowska E; Liżewska A; Kozłowski D; Raczak G
Pol Arch Med Wewn; 2015; 125(6):424-33. PubMed ID: 26038944
[TBL] [Abstract][Full Text] [Related]
14. Atrial natriuretic peptide response to cardioversion of atrial flutter and fibrillation and role of associated heart failure.
Mookherjee S; Anderson G; Smulyan H; Vardan S
Am J Cardiol; 1991 Feb; 67(5):377-80. PubMed ID: 1825258
[TBL] [Abstract][Full Text] [Related]
15. Plasma atrial natriuretic peptide levels for predicting the outcome of atrial fibrillation.
Arad M; Shotan A; Weinberger A; Aurbach I; Rabinowitz B
Cardiology; 2001; 95(2):74-9. PubMed ID: 11423710
[TBL] [Abstract][Full Text] [Related]
16. ANP and BNP in atrial fibrillation before and after cardioversion--and their relationship to cardiac volume and function.
Therkelsen SK; Groenning BA; Kjaer A; Svendsen JH; Boje Jensen G
Int J Cardiol; 2008 Jul; 127(3):396-9. PubMed ID: 17628724
[TBL] [Abstract][Full Text] [Related]
17. Clinical, adrenergic and heart endocrine measures in chronic atrial fibrillation as predictors of conversion and maintenance of sinus rhythm after direct current cardioversion.
Theodorakis GN; Markianos M; Kouroubetsis CK; Livanis EG; Paraskevaidis IA; Kremastinos DT
Eur Heart J; 1996 Apr; 17(4):550-6. PubMed ID: 8733088
[TBL] [Abstract][Full Text] [Related]
18. Effect of sinus rhythm restoration after electrical cardioversion on apelin and brain natriuretic Peptide prohormone levels in patients with persistent atrial fibrillation.
Kallergis EM; Manios EG; Kanoupakis EM; Mavrakis HE; Goudis CA; Maliaraki NE; Saloustros IG; Milathianaki ME; Chlouverakis GI; Vardas PE
Am J Cardiol; 2010 Jan; 105(1):90-4. PubMed ID: 20102897
[TBL] [Abstract][Full Text] [Related]
19. Exercise-induced natriuretic peptide secretion predicts cardioversion outcome in patients with persistent atrial fibrillation: discordant ANP and B-type natriuretic peptide response to exercise testing.
Wozakowska-Kaplon B; Opolski G
Pacing Clin Electrophysiol; 2010 Oct; 33(10):1203-9. PubMed ID: 20487352
[TBL] [Abstract][Full Text] [Related]
20. Plasma levels of NT-pro-BNP in patients with atrial fibrillation before and after electrical cardioversion.
Shin DI; Jaekel K; Schley P; Sause A; Müller M; Fueth R; Scheffold T; Guelker H; Horlitz M
Z Kardiol; 2005 Dec; 94(12):795-800. PubMed ID: 16382379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
